PGGM Investments Purchases 4,106 Shares of DaVita Inc. (NYSE:DVA)

PGGM Investments boosted its stake in DaVita Inc. (NYSE:DVA - Free Report) by 57.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,293 shares of the company's stock after purchasing an additional 4,106 shares during the period. PGGM Investments' holdings in DaVita were worth $1,689,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. SBI Securities Co. Ltd. bought a new stake in DaVita in the 4th quarter worth approximately $41,000. Quarry LP purchased a new position in shares of DaVita during the 3rd quarter worth $60,000. Venturi Wealth Management LLC boosted its stake in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. lifted its stake in shares of DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after buying an additional 131 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Price Performance

DVA stock traded up $0.03 during mid-day trading on Tuesday, hitting $149.27. The company had a trading volume of 673,871 shares, compared to its average volume of 780,848. The company has a market capitalization of $11.94 billion, a price-to-earnings ratio of 13.90, a P/E/G ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a 50-day moving average price of $158.87 and a 200 day moving average price of $157.62.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DVA shares. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.